EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Assessing the iLet Bionic Pancreas Deployed in Primary Care and via Telehealth: A Randomized Clinical Trial

Sean M. Oser, Melissa S. Putman, Steven J. Russell, Elizabeth B. Westfeldt, Kelsey B. Huss, Britney K. Prince, Jessica A. Parascando, Mollie Y. O’Connor, Amy Sabean, Annabelle L. Ashley, Evelyn G. Greaux, Rachel J. Bartholomew, Sarah Gaston, Nillani Anandakugan, Hui Zheng, Courtney A. Balliro, Mallory A. Hillard, Edward R. Damiano, Tamara K. Oser

Clinical Diabetes · 2025-07-15 · 43 (3) · 388-398

DOI: 10.2337/cd24-0104 ↗
AbstractBibliografische Angaben

Abstract

The iLet Bionic Pancreas system can improve glycemia in individuals with type 1 diabetes with its simple interface, setup, and maintenance, making it practical for use in the primary care setting and via telehealth (TH). This multisite, random-order crossover trial included 40 adults with type 1 diabetes who received care either from an endocrinology or a primary care clinic and were seen either in person or via TH. Of these 40 participants, 97% achieved an average glucose (AG) <183 mg/dL, and 64% achieved an AG <154 mg/dL. These results suggest that the system can be initiated effectively by primary care providers and via TH, potentially expanding access to this technology to a broad population, including individuals who cannot easily access subspecialty diabetes care.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →